Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02728128 · ClinicalTrials.gov registry record
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
A clinical trial of Heart Failure and Congenital Heart Disease, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 53
- Enrollment target
- 1
- Study location
NCT02728128: Completed study of Heart Failure and Congenital Heart Disease, sponsored by University of Colorado, Denver.
NCT02728128 is a study of Heart Failure and Congenital Heart Disease that has completed, run by University of Colorado, Denver. The registered enrollment target is 53 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02728128, a study of Heart Failure and Congenital Heart Disease, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify if circulating platelet cyclic adenosine monophosphate (cAMP) levels can be used as a biomarker of milrinone efficacy in children following cardiac surgery or undergoing heart transplant.
Primary Outcome
Criteria for low cardiac output
Conditions Studied
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-08-17 |
What the finished NCT02728128 record still lists
NCT02728128 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT02728128 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02728128 about?
NCT02728128 is a clinical study titled "Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children". The purpose of this study is to identify if circulating platelet cyclic adenosine monophosphate (cAMP) levels can be used as a biomarker of milrinone efficacy in children following cardiac surgery or undergoing heart transplant.
What is the current status of trial NCT02728128?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2016-08. Estimated completion is 2017-08-17.
What conditions does trial NCT02728128 study?
This clinical trial studies the following conditions: Heart Failure, Congenital Heart Disease, Pediatrics, Therapeutics.
Who is sponsoring clinical trial NCT02728128?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02728128 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02728128's enrollment target sits among peer trials
53 277th of 397 higher than 119 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia